What You Should Know: - Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved immune-oncology treatments, announced it has extended its Series A financing to over $25 million. IBF and Peregrine Ventures led the round, with participation from aMoon Fund and other existing investors. - The funding will be used to support the ongoing clinical evaluation of NTX1088, and to further advance the company’s pipeline of
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
RNSA22: NVIDIA Partners With NHS Trusts to Deploy AI Platform in UK Hospitals
What You Should Know: - A consortium of 10 National Health Service Trusts — the publicly funded healthcare system in England — is now deploying the MONAI-based AIDE platform across four of its hospitals, providing artificial intelligence (AI)-enabled disease-detection tools to healthcare professionals serving 5 million patients a year. - AIDE, short for AI Deployment Engine, is expected to be rolled out next year across 11 NHS hospitals serving 18 million patients, bringing AI
Read More
Lunit, CARPL.ai Partner to Accelerate AI-Powered Medical Imaging
What You Should Know: - Lunit signed a global distribution agreement to provide its AI-based radiology solutions for clinical use via CARPL.ai’s platform. Lunit is a South Korean-based AI software company devoted to developing AI solutions for precision diagnostics and treatment support, mainly focused on conquering cancer. - The partnership will deliver Lunit INSIGHT CXR and Lunit INSIGHT MMG for commercial use in the U.S., Australia, Brazil, India, and Singapore. CARPL
Read More
Oatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in Oklahoma
What You Should Know: - Central Oklahoma Family Medical Center FQHC (The Clinic) has selected Oatmeal Health, a veteran-owned Patient Success Service to bring tech-enabled lung cancer screenings to their patients. - As part of the partnership, Oatmeal Health will provide white-glove, concierge service, offering our support without FQHC’s shouldering the burden or cost. Tech-Enabled Lung Cancer Screening Currently, lung screening rates hover at around 4 percent
Read More
HLTH22 Day 3 News Summary
DispatchHealth Raises $330M for Hospital-at-Home Care DispatchHealth, a provider of in-home medical care raises $330M led by Optum Ventures with support from current investors such as Humana (NYSE: HUM), Oak HC/FT, Echo Health Ventures and Questa Capital. New investors included Adams Street Partners, the Olayan Group, Silicon Valley Bank, Pegasus Tech Ventures and Blue Shield of California. Patients and their care partners can request DispatchHealth medical care via phone, mobile app, or
Read More
Haystack Oncology Launches with $56M for Post-Op Cancer Detection Tech
What You Should Know: - Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology raises $56M in Series A financing led by Catalio Capital Management ("Catalio"), which co-founded Haystack through its private equity and structured equity investment vehicles. Additional investors include Bruker, Exact Ventures, the venture arm of Exact Sciences and Alexandria Venture
Read More
HLTH22: COTA and Google Partner to Use NLP to Harness Unstructured Oncology Data
What You Should Know: COTA, Inc., an oncology real-world data and analytics company announced a partnership with Google Cloud to bring clarity to unstructured oncology data through the latest advancements in machine learning and natural language processing. - Many leading real-world data companies - including COTA - leverage clinicians to manually curate oncology real-world data. While this is a reliable and trusted near-term solution to overcoming the challenges associated with
Read More
18 HLTH 2022 Predictions from Digital Health Executives to Watch
Before HLTH 2022 kicks off next week in Las Vegas, we asked 18 digital health executives for their predictions and major themes to expect at HLTH. 1. Keith Reynolds, Chief Operating Officer at Welldoc Access to care is a central focus for healthcare given several factors: a growing population being impacted with chronic conditions, increased resourcing constraints, and growing fatigue and workload among providers. A recent study indicated that it would require a PCP 26.7 hours/ day
Read More
AI ‘s Role in Drug Discovery: Separating the Hype from the Hope
Forecasting the influence that artificial intelligence (AI)/machine learning technologies will have on the future of healthcare has created a cottage industry in the hype. From the overzealous aspirations of IBM’s Watson Health initiative to the inclusion of AI on Gartner’s 2021 Hype Cycle at the “Peak of Inflated Expectations,” so much noise has been made around AI/machine learning in healthcare that it can be difficult to appreciate the current impact of these technologies on drug discovery,
Read More
JPMorgan Establishes Life Sciences Private Equity Division
What You Should Know: - J.P. Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. - The new team will focus on investing in both early and growth-stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity,
Read More
